Development of a whole-cell biosensor for β-lactamase inhibitor discovery
Chemical Communications · 2023
DOI: 10.1039/d3cc03583b ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2023. Verfasst von Mitchell A Jeffs und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada. christopher.lohans@queensu.ca. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
We developed a whole-cell biosensor that quantifies β-lactamase inhibition in a cellular context. This assay accounts for factors such as membrane permeability and can be used to identify novel β-lactamase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada. christopher.lohans@queensu.ca.
- Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Jeffs, M. A., Gray, R. A. V., Sheth, P. M., & Lohans, C. T. (2023). Development of a whole-cell biosensor for β-lactamase inhibitor discovery. Chemical Communications. https://doi.org/10.1039/d3cc03583b
Vancouver
Jeffs MA, Gray RAV, Sheth PM, Lohans CT. Development of a whole-cell biosensor for β-lactamase inhibitor discovery. Chemical Communications. 2023. doi:10.1039/d3cc03583b
BibTeX
@article{Jeffs2023,
author = {Jeffs, Mitchell A and Gray, Rachel A V and Sheth, Prameet M and Lohans, Christopher T},
title = {Development of a whole-cell biosensor for β-lactamase inhibitor discovery},
journal = {Chemical Communications},
year = {2023},
doi = {10.1039/d3cc03583b}
}
EUVIMED